The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV) rose nearly 4% in the week, outpacing the broader markets. On a ...

Shares of Hikma Pharmaceuticals PLC HIK slid 1.18% to £20.04 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.20% to 9,120.31 ...

Hikma Pharmaceuticals PLC closed 14.07% short of its 52-week high of £23.60, which the company reached on February 13th.

Ascendis’ likely approval of TransCon CNP for achondroplasia poses a major threat to BioMarin’s best-selling drug. Read why I ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top priorities for the rest of 2025. The 12 executives featured in this article are all speaking at ...

So let's assess the underlying fundamentals over the last 3 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...